- Home
- THRD vs KGEI Comparison
THRD vs KGEI Comparison
Compare THRD & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- KGEI
- Stock Information
- Founded
- THRD 2019
- KGEI 2008
- Country
- THRD United States
- KGEI United States
- Employees
- THRD N/A
- KGEI N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- KGEI
- Sector
- THRD Health Care
- KGEI
- Exchange
- THRD Nasdaq
- KGEI Nasdaq
- Market Cap
- THRD 232.4M
- KGEI 262.6M
- IPO Year
- THRD 2022
- KGEI N/A
- Fundamental
- Price
- THRD $5.25
- KGEI $7.04
- Analyst Decision
- THRD Hold
- KGEI Strong Buy
- Analyst Count
- THRD 3
- KGEI 1
- Target Price
- THRD $5.00
- KGEI $11.00
- AVG Volume (30 Days)
- THRD 296.2K
- KGEI 108.9K
- Earning Date
- THRD 05-08-2025
- KGEI 05-14-2025
- Dividend Yield
- THRD N/A
- KGEI N/A
- EPS Growth
- THRD N/A
- KGEI 42.54
- EPS
- THRD N/A
- KGEI 0.57
- Revenue
- THRD N/A
- KGEI $60,739,000.00
- Revenue This Year
- THRD N/A
- KGEI $32.19
- Revenue Next Year
- THRD N/A
- KGEI $33.24
- P/E Ratio
- THRD N/A
- KGEI $12.36
- Revenue Growth
- THRD N/A
- KGEI 20.06
- 52 Week Low
- THRD $3.18
- KGEI $2.85
- 52 Week High
- THRD $16.02
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- THRD 75.64
- KGEI 54.15
- Support Level
- THRD $5.16
- KGEI $7.00
- Resistance Level
- THRD $5.22
- KGEI $7.72
- Average True Range (ATR)
- THRD 0.04
- KGEI 0.41
- MACD
- THRD -0.03
- KGEI 0.11
- Stochastic Oscillator
- THRD 100.00
- KGEI 56.41
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.